% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • tradingexpert4me tradingexpert4me Dec 7, 2012 10:20 AM Flag

    PH II patient enrollment to small and that's why results are not very significant. PH III interim data this time

    TEVA didn't put up any upfront CASH. Now they may scoop up some shares following the next STOCK DILUTION, but that's about the best you can expect from TEVA.....

    BOTTOM LINE: Best buy hold LONGS can hope for now, is still over $2.00 per share when CEO Ahn dilutes the hell out of it again to raise badly needed cash.


2.10-0.05(-2.33%)Jun 24 4:00 PMEDT